A study led by�NYU Langone Health researchers sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.� ...

Novartis stock popped Thursday — prompting Travere Therapeutics to slide — after winning FDA approval for a kidney disease treatment.

A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a ...

Discover delicious high-protein breakfast recipes to kickstart your day. From smoothies to omelets, fuel up with these energizing — and cheap — meals.

There is growing concern that plastics may also be responsible for significant harm to the earth’s environment and human ...